NeuroPace Inc SEC filings NPCE

NeuroPace Inc has 353 filings in SEC EDGAR's recent list, going back to Aug 30, 2011. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

NeuroPace Inc SEC filings
Form Description Filed Period
EFFECT Filing Nov 22, 2022 —
EFFECT Filing Apr 21, 2021 —
CORRESP Letter to the SEC Apr 21, 2021 —
CORRESP Letter to the SEC Apr 21, 2021 —
EFFECT Filing Apr 20, 2021 —
CERT Filing Apr 20, 2021 —
CORRESP Letter to the SEC Apr 16, 2021 —
CORRESP Letter to the SEC Apr 16, 2021 —
8-A12B Filing Apr 14, 2021 —
CORRESP Letter to the SEC Apr 9, 2021 —
UPLOAD Letter from the SEC Apr 7, 2021 —
CORRESP Letter to the SEC Apr 6, 2021 —
CORRESP Letter to the SEC Mar 24, 2021 —
UPLOAD Letter from the SEC Feb 25, 2021 —
DRS Filing Jan 29, 2021 —
D Filing Aug 31, 2020 —
D/A Filing Aug 8, 2017 —
D Filing Jan 9, 2017 —
D Filing Jul 9, 2013 —
D Filing Aug 30, 2011 —

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NPCE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Mountain View, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1528287

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.